In-Vivo CAR-T Enters Neurologic Autoimmunity

Institution: Tongji Hospital, Huazhong University of Science and Technology / Shenzhen Genocury Biotech · Platform: Non-Replicating Lentiviral In-Vivo CD19 CAR-T · Population: Neurologic Autoimmune Disease (16 Patients) · Study Type: Peer-Reviewed (NEJM Letter) · Date: September 3, 2026 Summary A peer-reviewed New England Journal of…